Rodolfo Chaparro, Ph.D

Rodolfo Chaparro is co-founder and scientific advisor of Crosslink Therapeutics and co-inventor of its technologies. Prior to that he was a co-founder/co-inventor of Cue Biopharma (NASDAQ: CUE).  At Cue, Dr. Chaparro served as EVP and head of immunology, being responsible for the Company's immuno-oncology and autoimmunity research programs as well as its preclinical and early clinical development. Prior to Cue Biopharma, Dr. Chaparro was a research faculty member in the Department of Biochemistry and MTDF at the Albert Einstein College of Medicine. Dr. Chaparro holds a B.S. in Biology from the University of California at Irvine and a Ph.D. in immunology from Stanford University.